Upgrade to SI Premium - Free Trial

Ovid Therapeutics (OVID)

2.69 +0.06 (2.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Ovid Therapeutics Inc (OVID) PT Raised to $5 at H.C. Wainwright September 11, 2026 6:56 AM - StreetInsider Ovid Therapeutics to Participate in Upcoming Investor Conferences September 3, 2026 8:00 AM - StreetInsider Form 144 Ovid Therapeutics Inc. Filed by: Rona Jeffrey A August 24, 2026 4:48 PM - SEC Filing Form 144 Ovid Therapeutics Inc. Filed by: Rona Jeffrey A August 14, 2026 6:28 PM - SEC Filing Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: ADAR1 Capital Management, LLC August 14, 2026 5:07 PM - SEC Filing Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. August 14, 2026 4:49 PM - SEC Filing Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC August 14, 2026 11:42 AM - SEC Filing Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P. August 14, 2026 6:14 AM - SEC Filing Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC August 13, 2026 4:10 PM - SEC Filing Form 10-Q Ovid Therapeutics Inc. For: Jun 30 August 13, 2026 8:33 AM - SEC Filing Form 8-K Ovid Therapeutics Inc. For: Aug 11 August 13, 2026 8:32 AM - SEC Filing Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results August 13, 2026 8:30 AM - StreetInsider Ovid Therapeutics Inc (OVID) PT Raised to $9 at Oppenheimer August 3, 2026 8:35 AM - StreetInsider Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: BlackRock, Inc. July 29, 2026 3:23 PM - SEC Filing B.Riley on Ovid Therapeutics Inc (OVID): 'one of our top picks from last week's B. Riley MMV Summit' July 21, 2026 5:16 AM - StreetInsider Form 4 Ovid Therapeutics Inc. For: Jul 06 Filed by: Carter Charles Ross July 8, 2026 4:32 PM - SEC Filing Form 3 Ovid Therapeutics Inc. For: Jul 06 Filed by: Carter Charles Ross July 8, 2026 4:28 PM - SEC Filing Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: FEDERATED HERMES, INC. July 8, 2026 7:55 AM - SEC Filing Form 8-K Ovid Therapeutics Inc. For: Jul 05 July 8, 2026 7:04 AM - SEC Filing Ovid Therapeutics names new CFO and CBO in leadership reshuffle July 8, 2026 7:02 AM - StreetInsider Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development July 8, 2026 7:00 AM - StreetInsider Form 4 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna June 17, 2026 4:22 PM - SEC Filing Form 3 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna June 17, 2026 4:20 PM - SEC Filing Full Article List